Abstract
Tyrosinemia type II is an autosomal recessive inborn error of metabolism caused by hepatic cytosolic tyrosine aminotransferase deficiency. Importantly, this disease is associated with neurological and developmental abnormalities in many patients. Considering that the mechanisms underlying neurological dysfunction in hypertyrosinemic patients are poorly understood, in the present work we investigated the levels of cytokines – tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and IL-10 - in cerebellum, hippocampus, striatum of young rats exposed to chronic administration of L-tyrosine. In addition, we also investigated the impact of the supplementation with Omega-3 fatty acids (n-3 PUFA) on the rodent model of Tyrosinemia. Notably, previous study demonstrated an association between L-tyrosine toxicity and n-3 PUFA deficiency. Our results showed a significant increase in the levels of pro- and anti-inflammatory cytokines in brain structures when animals were administered with L-tyrosine. Cerebral cortex and striatum seem to be more susceptible to the inflammation induced by tyrosine toxicity. Importantly, n-3 PUFA supplementation attenuated the alterations on cytokines levels induced by tyrosine exposure in brain regions of infant rats. In conclusion, the brain inflammation is also an important process related to tyrosine neurotoxicity observed in the experimental model of Tyrosinemia. Finally, n-3 PUFA supplementation could be considered as a potential neuroprotective adjunctive therapy for Tyrosinemias, especially type II.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Azodi S, Jacobson S (2016) Cytokine therapies in neurological disease. NeuroTherapeutics 13(3):555–561. https://doi.org/10.1007/s13311-016-0455-1
Barth BM, Gustafson SJ, Hankins JL, Kaiser JM, Haakenson JK, Kester M, Kuhn TB (2012) Ceramide kinase regulates TNFa-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells. Cell Signal 24(6):1126–1133. https://doi.org/10.1016/j.cellsig.2011.12.020
Baune BT, Konrad C, Grotegerd D, Suslow T, Birosova E, Ohrmann P, Bauer J, Arolt V, Heindel W, Domschke K, Schöning S, Rauch AV, Uhlmann C, Kugel H, Dannlowski U (2012) Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflammation 9:125. https://doi.org/10.1186/1742-2094-9-125
Beck RD Jr, Wasserfull C, Ha GK, Cushman JD, Huang Z, Atkinson MA, Petitto JM (2005) Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res 1041(2):223–230. https://doi.org/10.1016/j.brainres.2005.02.010
Beltz BS, Tlusty MF, Benton JL, Sandeman DC (2007) Omega-3 fatty acids upregulate adult neurogenesis. Neurosci Lett 415(2):154–158. https://doi.org/10.1016/j.neulet.2007.01.010
Bongiovanni R, Yamamoto BK, Simpson C, Jaskiw GE (2003) Pharmacokinetics of systemically administered tyrosine: a comparison of serum, brain tissue and in vivo microdialysate levels in the rat. J Neurochemistry 87(2):310–317. https://doi.org/10.1046/j.1471-4159.2003.02007.x
Bridi R, Fontella FU, Pulrolnik V, Braun CA, Zorzi GK, Coelho D, Wajner M, Vargas CR, Dutra-Filho CS (2006) A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155(2):224–230. https://doi.org/10.1016/j.jneumeth.2006.01.005
Buist NRM, Kennaway NG, Fellman JH (1995) Tyrosinemia type II. In: Bickel H, Wachtel V (eds) Inherited diseases of Aminoacid metabolism. Georg Thieme Verlag, Stuttgart, pp 203–235
Calder PC (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83(6):1505–1519. https://doi.org/10.1093/ajcn/83.6.1505S
Carvalho-Silva M, Gomes LM, Scaini G, Rebelo J, Damiani AP, Pereira M, Andrade VM, Gava FF, Valvassori SS, Schuck PF, Ferreira GC, Streck EL (2017) Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II. Metab Brain Dis 32(4):1043–1050. https://doi.org/10.1007/s11011-017-9994-3
Carvalho-Silva M, Gomes LM, de Prá SD, Wessler LB, Schuck PF, Scaini G, de Bem AF, Blum-Silva CH, Reginatto FH, de Oliveira J, Streck EL (2019a) Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats. Metab Brain Dis. https://doi.org/10.1007/s11011-019-00511-3
Carvalho-Silva M, Gomes LM, Gomes ML, Ferreira BK, Schuck PF, Ferreira GC, Dal-Pizzol F, De Oliveira J, Scaini G, Streck EL (2019b) Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats. Metab Brain Dis 34(4):1207–1219. https://doi.org/10.1007/s11011-019-00411-6
Charfeddine C, Monastiri K, Mokni M, Laadjimi A, Kaabachi N, Perin O, Nilges M, Kassar S, Keirallah M, Guediche MN, Kamoun MR, Tebib N, Ben Dridi MF, Boubaker S, Ben Osman A, Abdelhak S (2006) Clinical and mutational investigations of tirosinemia type II in northern Tunisia: IdentiWcation and structural characterization of two novel TAT mutations. Mol Gen Metabol 88(2):184–191. https://doi.org/10.1016/j.ymgme.2006.02.006
De Andrade RB, Gemelli T, Rojas DB, Bonorino NF, Costa BM, Funchal C, Dutra-Filho CS, Wannmacher CM (2011a) Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats. Mol Neurobiol 51(3):1184–1194. https://doi.org/10.1007/s12035-014-8791-9
De Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2011b) Tyrosine inhibits creatine kinase activity in cerebral cortex of young rats. Metab Brain Dis 26(3):221–227. https://doi.org/10.1007/s11011-011-9255-9
De Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2012) Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. Mol Cell Biochem 364(1–2):253–261. https://doi.org/10.1007/s11010-012-1225-y
De Prá SD, Ferreira GK, Carvalho-Silva M, Vieira JS, Scaini G, Leffa DD, Fagundes GE, Bristot BN, Borges GD, Ferreira GC, Schuck PF, Andrade VM, Streck EL (2014) L-tyrosine induces DNA damage in brain and blood of rats. Neurochem Res 39(1):202–207. https://doi.org/10.1007/s11064-013-1207-9
Dercksen M, Kulik W, Mienie LJ, Reinecke CJ, Wanders RJ, Duran M (2016) Polyunsaturated fatty acid status in treated isovaleric acidemia patients. Eur J Clin Nutr 70(10):1123–1126. https://doi.org/10.1038/ejcn.2016.100
El-Ansary AK, Al-Daihan SK, El-Gezeery AR (2011) On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups. Lipid Heal Disease 10:142. https://doi.org/10.1186/1476-511X-10-142
El-Badramany MH, Fawzy AR, Farag TI (1995) Familial Richner–Hanhart syndrome in Kuwait: twelve-year clinical reassessment by a multidisciplinary approach. Am J Med Genet 60(5):353–355. https://doi.org/10.1002/ajmg.1320600502
Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254–1266. https://doi.org/10.7150/ijbs.4679
Ferreira GK, Jeremias IC, Scaini G, Carvalho-Silva M, Gomes LM, Furlanetto CB, Morais MOS, Schuck PF, Ferreira GC, Streck EL (2013a) Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain. Neurochem Res 38(8):1742–1746. https://doi.org/10.1007/s11064-013-1078-0
Ferreira GK, Scaini G, Carvalho-Silva M, Gomes LM, Borges LS, Vieira JS, Constantino LS, Ferreira GC, Schuck PF, Streck EL (2013b) Effect of L-tyrosine in vitro and in vivo on energy metabolism parameters in brain and liver of young rats. Neurotox Res 23(4):327–335. https://doi.org/10.1007/s12640-012-9345-4
Ferreira GK, Carvalho-Silva M, Gomes LM, Scaini G, Teixeira LJ, Mota IT, Schuck PF, Ferreira GC, Streck EL (2015) The characterization of neuroenergetic effects of chronic L-tyrosine administration in young rats: evidence for striatal susceptibility. Metab Brain Dis 30(1):215–221. https://doi.org/10.1007/s11011-014-9615-3
Fialkow L, Wang Y, Downey GP (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42(2):153–164. https://doi.org/10.1016/j.freeradbiomed.2006.09.030
Fois A, Borgogni P, Cioni M, Molinelli M, Frezzotti R, Bardelli AM, Lasorella G, Barberi L, Durand P, DiRocco M, Romano C, Parini R, Corbetta C, Giovannini M, Riva E, Balato N, Sartorio R, Mollica F, Zammarchi E, Battini ML (1986) Presentation of the data of the Italian registry for oculocutaneous tyrosinaemia. J Inherit Metab Dis 9:262–264
Gadient RA, Otten U (1994) Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 182(2):243–246. https://doi.org/10.1016/0304-3940(94)90807-9
Galic MA, Riazi K, Pittman QJ (2012) Cytokines and brain excitability. Front Neuroendocrinol 33(1):116–125. https://doi.org/10.1016/j.yfrne.2011.12.002
Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, Hoh BL, Blackburn S, Doré S (2017) Role of Interleukin-10 in acute brain injuries. Front Neurol 8:244. https://doi.org/10.3389/fneur.2017.00244 eCollection 2017
Gil-Campos M, Sanjurjo Crespom P (2012) Omega 3 fatty acids and inborn errors of metabolism. Br J Nutr 107:129–136. https://doi.org/10.1017/S0007114512001523
Green P, Yavin E (1998) Mechanisms of docosahexaenoic acid accretion in the fetal brain. J Neurosci Res 52(2):129–136
Griffin WST, Barger SW (2010) Neuroinflammatory cytokines- the common thread in Alzheimer’s pathogenesis. US Neurol 6(2):19–27
Hanhart E (1947) Neue Sonderformen von Keratosis palmo-plantaris u.a. eine regelmaessig dominante mit systematisierten Lipomen, ferner zwei einfach rezessive mit Schwachsinn und z.t. mit Hornhautveraenderuengen des Auges (Ektodermalsyndrom). Dermatologica 94:286–308
Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model rats. J Neurochem 81(5):1084–1091. https://doi.org/10.1046/j.1471-4159.2002.00905.x
Heidmann DG, Durra SP, Bawle E, Shepherd DM (1989) Early diagnosis of tyrosine II. Am J Ophthalmol 107(5):559–560
Hühn R, Stoermer H, Klingele B, Bausch E, Fois A, Farnetani M, DiRocco M, Boue J, Kirk JM, Coleman R, Scherer G (1998) Novel and recurrent tyrosine aminotransferase gene mutations in tirosinemia type II. Hum Genet 102(3):305–313
Jans JJ, de Sain-van der Velden MG, van Hasselt PM, van den Hurk DT, Vaz FM, Visser G, Verhoeven-Duif NM (2013) Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU. Mol Genet Metab 109(2):121–124. https://doi.org/10.1016/j.ymgme.2013.03.006
Jeon SW, Kim YK (2016) Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness? World J Psychiatry 6(3):283–293. https://doi.org/10.5498/wjp.v6.i3.283
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R (2011) Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun 25(8):1725–1734. https://doi.org/10.1016/j.bbi.2011.07.229
Koletzko B, Beblo S, Demmelmair H, Hanebutt FL (2009) Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU). J Pediatr Gastroenterol Nutr 48:2–7. https://doi.org/10.1097/MPG.0b013e3181977399
Kymionis GD, Kankariya VP, Kontadakis GA, Ziakas NG (2012) Isolated corneal Pseudodendrites as the initial manifestation of Tyrosinemia type II in monozygotic twins. J Pediatr Ophthalmol Strabismus 49:33–36. https://doi.org/10.3928/01913913-20120501-03
Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69(1):94–103. https://doi.org/10.1002/jnr.10253
Lim S, Suzuki H (2001) Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. J Nutr 131(2):319–324. https://doi.org/10.1093/jn/131.2.319
Liu Z, Martin LJ (2001) Motor neurons rapidly accumulate DNA single-strand breaks after in vitro exposure to nitric oxide and peroxynitrite and in vivo axotomy. J Comp Neurol 432(1):35–60. https://doi.org/10.1002/cne.1087
Llesuy SF, Milei J, Molina H, Boveris A, Milei S (1985) Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4_-epiadriamycin in mice. Tumori 71(3):241–249
Lowry OH, Rosenbrough NJ, Farr A, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193(1):265–275
Lurie DI (2018) An integrative approach to Neuroinflammation in psychiatric disorders and neuropathic pain. J Exp Neurosci 12:1179069518793639. https://doi.org/10.1177/1179069518793639 eCollection 2018
Macêdo LG, Carvalho-Silva M, Ferreira GK, Vieira JS, Olegário N, Gonçalves RC, Vuolo FS, Ferreira GC, Schuck PF, Dal-Pizzol F, Streck EL (2013) Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats. Neurochem Res 38(12):2625–2630. https://doi.org/10.1007/s11064-013-1180-3
Martin LJ, Pan Y, Price AC, Sterling W, Compeland NG, Jenkins NA, Price DL, Lee MK (2006) Parkinson’s disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26(1):41–50. https://doi.org/10.1523/JNEUROSCI.4308-05.2006
Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, Golden WC (2007) Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase–1 transgenic mice: mechanisms of mitochondriopathy and cell death. J Comp Neurol 500(1):20–46. https://doi.org/10.1002/cne.21160
Mazer LM, Yi SH, Singh RH (2010) Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. J Inherit Metab Dis 33(2):121–127. https://doi.org/10.1007/s10545-010-9066-x
McAnulty SR, Nieman DC, Fox-Rabinovich M, Duran V, McAnulty LS, Henson DA, Jin F, Landram MJ (2010) Effect of n-3 fatty acids and antioxidants on oxidative stress after exercise. Med Sci Sports Exerc 42(9):1704–1711. https://doi.org/10.1249/MSS.0b013e3181d85bd1
Mcgahon BM, Martin DS, Horrobin DF, Lynch MA (1999) Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94(1):305–314
Miller VM, Lawrence DA, Coccaro GA, Mondal TK, Andrews K, Dreiem A, Seegal RF (2010) Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice. Brain Res 1318:11–22. https://doi.org/10.1016/j.brainres.2009.12.091
Mitchell GA, Grompe M, Lambert M, Tanguay RM (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1977–1982
Morre MC, Hefti F, Wurtman RJ (1980) Regional tyrosine levels in rat brain after tyrosine administration. J Neural Transm 49:45–50
Mrak RE, Griffin WS (2005) Potential inflammatory biomarkers in Alzheimer’s disease. J Alzheimers Dis 8(4):369–375. https://doi.org/10.3233/JAD-2005-8406
Nakafuku M, Satoh T, Kaziro Y (1992) Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 267(27):19448–19454
Paker AM, Sunness JS, Brereton NH, Speedie LJ, Albanna L, Dharmaraj S, Moser AB, Jones RO, Raymond GV (2010) Docosahexaenoic acid therapy in peroxisomal diseases: results of a double-blind, randomized trial. Neurology 75(9):826–830. https://doi.org/10.1212/WNL.0b013e3181f07061
Peña-Quintana L, Scherer G, Curbelo-Estévez ML, Jiménez-Acosta F, Hartmann B, Roche F, Meavilla-Olivas S, Pérez-Cerdá C, García Segarra N, Giguère Y, Huppke P, Mitchell GA, Mönch E, Trump D, Vianey-Saban C, Trimble ER, Vitoria-Miñana I, Reyes-Suárez D, Ramírez-Lorenzo T, Tugores A (2017) Tyrosinemia type II: mutation update, eleven novel mutations and description of five independent subjects with a novel founder mutation. Clin Genet 92(3):306–317. https://doi.org/10.1111/cge.13003
Ramos AC, Ferreira GK, Carvalho-Silva M, Furlanetto CB, Gonçalves CL, Ferreira GC, Schuck PF, Streck EL (2013) Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats. Int J Dev Neurosci 31(5):303–307. https://doi.org/10.1016/j.ijdevneu.2013.03.005
Rice DN, Houston IB, Lyon IC, Macarthur BA, Mullins PR, Veale AM, Guthrie R (1989) Transient neonatal tyrosinaemia. Inherit Metab Dis 12(1):13–22
Richner H (1938) Horhauta Vektion bei Keratoma palmare et plantare hereditarium. Klin Mbl Augenheilk 100:580–588
Salem N, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36(9):945–959. https://doi.org/10.1007/s11745-001-0805-6
Schmidt S, Stahl F, Mutz KO, Scheper T, Hahn A, Schuchardt JP (2012) Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men. Nutr Metab 9(1):45. https://doi.org/10.1186/1743-7075-9-45
Serhan CN, Chiang N, Dalli J, Levy BD (2014) Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 7(2):a016311. https://doi.org/10.1101/cshperspect.a016311
Sgaravatti AM, Vargas BA, Zandoná BR, Deckmann KB, Rockenbach FJ, Moraes TB, Monserrat JM, Sgarbi MB, Pederzolli CD, Wyse ATS, Wannmacher CMD, Wajner M, Dutra- Filho CS. (2008) Tyrosine promotes oxidative stress in cerebral cortex of young rats. Int J Dev Neurosci 26(6):551–559. https://doi.org/10.1016/j.ijdevneu.2008.05.007
Sgaravatti AM, Magnusson AS, De Oliveira AS, Rosa AP, Mescka CP, Zanin FR, Pederzolli CD, Wyse AT, Wannmacher CM, Wajner M, Dutra-Filho CS (2009) Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex. Metab Brain Dis 24(3):415–425. https://doi.org/10.1007/s11011-009-9153-6
Shasi VK, Pratap RMP, Rao SL (1997) Inhibition of tyrosine aminotransferase by beta-N-oxalyl-L-alpha, beta-diaminopropionic acid, the Lathyrus sativus neurotoxin. J Neurochem 68(6):2477–2484. https://doi.org/10.1046/j.1471-4159.1997.68062477.x
Siracusa R, Fusco R, Cuzzocrea S (2019) Astrocytes: role and functions in brain pathologies. Front Pharmacol 10:1114. https://doi.org/10.3389/fphar.2019.01114 eCollection 2019
Song C, Zhang XY, Manku M (2009) Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 29(1):14–22. https://doi.org/10.1523/JNEUROSCI.3569-08.2009
Streck EL, De Prá SD, Ferro PR, Carvalho-Silva M, Gomes LM, Agostini JF, Damiani A, Andrade VM, Schuck PF, Ferreira GC, Scaini G (2017) Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II. Mol Cell Biochem 435:207–214. https://doi.org/10.1007/s11010-017-3070-5
Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW (2001) Interleukin-10 in the brain. Crit Rev Immunol 21(5):427–449
Suzuki H, Park SJ, Tamura M, Ando S (1998) Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Age Develop 101:119–128. https://doi.org/10.1016/S0047-6374(97)00169-3
Vlaardingerbroek H, Hornstra G, De Koning TJ, Smeitink JA, Bakker HD, De Klerk HB, Rubio-Gozalbo ME (2006) Essential polyunsaturated fatty acids in plasma and erythrocytes of children with inborn errors of amino acid metabolism. Mol Genet Metab 88(2):159–165. https://doi.org/10.1016/j.ymgme.2006.01.012
Wani AL, Bhat SA, Ara A (2015) Omega-3 fatty acids and the treatment of depression: a review of scientific evidence. Integr Med Res 4(3):132–141. https://doi.org/10.1016/j.imr.2015.07.003
Williams ML (1988) Ichthyosis and disorders of comification. In: Schachner LA, Hansen RC (eds) Pediatric dermatology. Churchill Livingstone Books Co, Philadelphia, pp 421–423
Zhang W, Li P, Hu X, Zhang F, Chen J, Gao Y (2011) Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection. Front Biosci 16:2653–2670. https://doi.org/10.2741/3878
Acknowledgments
This research was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC) and Universidade do Extremo Sul Catarinense (UNESC). The authors report no biomedical financial interests or potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Antonini, R., Scaini, G., Michels, M. et al. Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine. Metab Brain Dis 35, 295–303 (2020). https://doi.org/10.1007/s11011-019-00525-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-019-00525-x